Madelyn A. Gillentine,Tianyun Wang,Kendra Hoekzema,Jill Rosenfeld,Pengfei Liu,Hui Guo,Chang N. Kim,Bert B. A. De Vries,Lisenka E. L. M. Vissers,Magnus Nordenskjold,Malin Kvarnung,Anna Lindstrand,Ann Nordgren,Jozef Gecz,Maria Iascone,Anna Cereda,Agnese Scatigno,Silvia Maitz,Ginevra Zanni,Enrico Bertini,Christiane Zweier,Sarah Schuhmann,Antje Wiesener,Micah Pepper,Heena Panjwani,Erin Torti,Farida Abid,Irina Anselm,Siddharth Srivastava,Paldeep Atwal,Carlos A. Bacino,Gifty Bhat,Katherine Cobian,Lynne M. Bird,Jennifer Friedman,Meredith S. Wright,Bert Callewaert,Florence Petit,Sophie Mathieu,Alexandra Afenjar,Celenie K. Christensen,Kerry M. White,Orly Elpeleg,Itai Berger,Edward J. Espineli,Christina Fagerberg,Charlotte Brasch-Andersen,Lars Kjærsgaard Hansen,Timothy Feyma,Susan Hughes,Isabelle Thiffault,Bonnie Sullivan,Shuang Yan,Kory Keller,Boris Keren,Cyril Mignot,Frank Kooy,Marije Meuwissen,Alice Basinger,Mary Kukolich,Meredith Philips,Lucia Ortega,Margaret Drummond-Borg,Mathilde Lauridsen,Kristina Sorensen,Anna Lehman,Elena Lopez-Rangel,Paul Levy,Davor Lessel,Timothy Lotze,Suneeta Madan-Khetarpal,Jessica Sebastian,Jodie Vento,Divya Vats,L. Manace Benman,Shane Mckee,Ghayda M. Mirzaa,Candace Muss,John Pappas,Hilde Peeters,Corrado Romano,Maurizio Elia,Ornella Galesi,Marleen E. H. Simon,Koen L. I. van Gassen,Kara Simpson,Robert Stratton,Sabeen Syed,Julien Thevenon,Irene Valenzuela Palafoll,Antonio Vitobello,Marie Bournez,Laurence Faivre,Kun Xia,John Acampado,Rachel K. Earl,Tomasz Nowakowski,Raphael A. Bernier,Evan E. Eichler

Abstract:Background With the increasing number of genomic sequencing studies, hundreds of genes have been implicated in neurodevelopmental disorders (NDDs). The rate of gene discovery far outpaces our understanding of genotype–phenotype correlations, with clinical characterization remaining a bottleneck for understanding NDDs. Most disease-associated Mendelian genes are members of gene families, and we hypothesize that those with related molecular function share clinical presentations. Methods We tested our hypothesis by considering gene families that have multiple members with an enrichment of de novo variants among NDDs, as determined by previous meta-analyses. One of these gene families is the heterogeneous nuclear ribonucleoproteins (hnRNPs), which has 33 members, five of which have been recently identified as NDD genes ( HNRNPK , HNRNPU , HNRNPH1 , HNRNPH2 , and HNRNPR ) and two of which have significant enrichment in our previous meta-analysis of probands with NDDs ( HNRNPU and SYNCRIP ). Utilizing protein homology, mutation analyses, gene expression analyses, and phenotypic characterization, we provide evidence for variation in 12 HNRNP genes as candidates for NDDs. Seven are potentially novel while the remaining genes in the family likely do not significantly contribute to NDD risk. Results We report 119 new NDD cases (64 de novo variants) through sequencing and international collaborations and combined with published clinical case reports. We consider 235 cases with gene-disruptive single-nucleotide variants or indels and 15 cases with small copy number variants. Three hnRNP-encoding genes reach nominal or exome-wide significance for de novo variant enrichment, while nine are candidates for pathogenic mutations. Comparison of HNRNP gene expression shows a pattern consistent with a role in cerebral cortical development with enriched expression among radial glial progenitors. Clinical assessment of probands ( n = 188–221) expands the phenotypes associated with HNRNP rare variants, and phenotypes associated with variation in the HNRNP genes distinguishes them as a subgroup of NDDs. Conclusions Overall, our novel approach of exploiting gene families in NDDs identifies new HNRNP -related disorders, expands the phenotypes of known HNRNP -related disorders, strongly implicates disruption of the hnRNPs as a whole in NDDs, and supports that NDD subtypes likely have shared molecular pathogenesis. To date, this is the first study to identify novel genetic disorders based on the presence of disorders in related genes. We also perform the first phenotypic analyses focusing on related genes. Finally, we show that radial glial expression of these genes is likely critical during neurodevelopment. This is important for diagnostics, as well as developing strategies to best study these genes for the development of therapeutics.

Heterozygous deletion of the LRFN2 gene is associated with working memory deficits

Novel syndromic neurodevelopmental disorder caused by de novo deletion of , a long noncoding RNA

Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures

Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors

Rare predicted deleterious FEZF2 variants are associated with a neurodevelopmental phenotype

Phenotypic complexities of rare heterozygous neurexin-1 deletions

GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila

Novel syndromic neurodevelopmental disorder caused by de novo deletion of CHASERR, a long noncoding RNA

Visuospatial working memory in children and adolescents with 22q11.2 deletion syndrome; an fMRI study

Loss-of-function variant in the LRR domain of SLITRK2 implicated in a neurodevelopmental disorder

Exonic Deletions in AUTS2 Cause a Syndromic Form of Intellectual Disability and Suggest a Critical Role for the C Terminus

Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy

8p23.2-pter Microdeletions: Seven New Cases Narrowing the Candidate Region and Review of the Literature

9q33.3q34.11 microdeletion: new contiguous gene syndrome encompassing STXBP1, LMX1B and ENG genes assessed using reverse phenotyping

Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders

X-exome Sequencing of 405 Unresolved Families Identifies Seven Novel Intellectual Disability Genes.

Synaptic-dependent developmental dysconnectivity in 22q11.2 deletion syndrome

Executive function deficits in genetic frontotemporal dementia: results from the GENFI study

Altered medial prefrontal cortex and dorsal raphé activity predict genotype and correlate with abnormal learning behavior in a mouse model of autism-associated 2p16.3 deletion

NF1 Microdeletion Syndrome: Refined FISH Characterization of Sporadic and Familial Deletions with Locus-Specific Probes